Adamas Pharmaceuticals
ADMS
#7196
Rank
โ‚ฌ0.33 B
Marketcap
7,24ย โ‚ฌ
Share price
0.00%
Change (1 day)
15,383.25%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): โ‚ฌ74.33 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is โ‚ฌ77.62 Million. In 2020 the company made a revenue of โ‚ฌ65.54 Million an increase over the revenue in the year 2019 that were of โ‚ฌ48.09 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ74.33 M13.42%
2020โ‚ฌ65.54 M36.28%
2019โ‚ฌ48.09 M60.48%
2018โ‚ฌ29.96 M
2016โ‚ฌ0.5 M-70.15%
2015โ‚ฌ1.68 M-96.57%
2014โ‚ฌ49.15 M-21.45%
2013โ‚ฌ62.57 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ71.9 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.58 B 650.45%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ49.58 B 63,778.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ35.36 B 45,461.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ56.48 B 72,661.91%๐Ÿ‡บ๐Ÿ‡ธ USA